Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Hypercalcemia
- A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM
- Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
- The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH
- Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
- Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
- Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma
- ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
- Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
- An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
- One Week Comparison Study of PTH and PTHrP Infusions
- Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice
- Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
- Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
- Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
- Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose
- Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.
- Effect of Vitamin D Treatment in Primary Hyperparathyroidism
- Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
- One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
- Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone
- Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
- Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
- S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone
- Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community
- Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
- Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
- Studies of Elevated Parathyroid Activity